ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Onyx Pharmaceuticals, Inc. 

249 E. Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-266-0000 Fax: 650-266-0100


SEARCH JOBS

About Onyx Pharmaceuticals, Inc.

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com. Onyx Pharmaceuticals is on Twitter. Sign up to follow our Twitter feed @OnyxPharm at http://twitter.com/OnyxPharm.


 Key Statistics


Email:
Ownership: Public

Web Site: Onyx Pharmaceuticals, Inc.
Employees: 900
Symbol: ONXX
 



Industry
Biotechnology






 Company News
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Nexavar Misses Target In Phase 3 Liver Cancer Trial 3/11/2014 6:25:33 AM    More...
Ligand Pharmaceuticals Inc. (LGND) To Receive $1 Million Kyprolis® Commercial Milestone Payment From Onyx Pharmaceuticals, Inc. (ONXX) 2/11/2014 8:48:15 AM    More...
The International Myeloma Foundation Announces Partnership With Onyx Pharmaceuticals, Inc. (ONXX) To Support Black Swan Research Initiative™ 12/9/2013 10:52:11 AM    More...
FDA Approves Bayer HealthCare (BAY), Onyx Pharmaceuticals, Inc. (ONXX)'s NEXAVAR® To Treat Type Of Thyroid Cancer 11/25/2013 6:21:12 AM    More...
Amgen (AMGN) and Onyx Pharmaceuticals, Inc. (ONXX) Announce Upcoming Data Presentations at 55th American Society of Hematology Annual Meeting 11/8/2013 7:18:29 AM    More...
Tony Coles, Former Onyx Pharmaceuticals, Inc. (ONXX) Chairman and CEO, to Give Keynote at BIO-Europe® 2013 in Vienna November 4–6 10/7/2013 7:35:15 AM    More...
Amgen (AMGN) Successfully Completes Onyx Pharmaceuticals, Inc. (ONXX) Tender Offer 10/1/2013 8:48:10 AM    More...
Amgen (AMGN) and Onyx Pharmaceuticals, Inc. (ONXX) Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx 9/19/2013 9:56:29 AM    More...
Lawsuits Aim to Kill Onyx Pharmaceuticals, Inc. (ONXX)-Amgen (AMGN) Deal 9/9/2013 8:39:31 AM    More...
Onyx Pharmaceuticals, Inc. (ONXX) CEO Could Snag $62 Million if He Leaves After Amgen (AMGN) Takeover 9/4/2013 7:56:24 AM    More...
12345678910...